Skip to main content

Sex Differences in Depression and Anxiety

  • Chapter
  • First Online:
Sex Differences in Brain Function and Dysfunction

Part of the book series: Current Topics in Behavioral Neurosciences ((CTBN,volume 62))

Abstract

Depression and anxiety disorders carry a tremendous worldwide burden and emerge as a significant cause of disability among western societies. Both disorders are known to disproportionally affect women, as they are twice more likely to be diagnosed and moreover, they are also prone to suffer from female-specific mood disorders. Importantly, the prevalence of these affective disorders has notably risen after the COVID pandemic, especially in women. In this chapter, we describe factors that are possibly contributing to the expression of such sex differences in depression and anxiety. For this, we overview the effect of transcriptomic and genetic factors, the immune system, neuroendocrine aspects, and cognition. Furthermore, we also provide evidence of sex differences in antidepressant response and their causes. Finally, we emphasize the importance to consider sex as a biological variable in preclinical and clinical research, which may facilitate the discovery and development of new and more efficacious antidepressant and anxiolytic pharmacotherapies for both women and men.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Agid Y, Buzsáki G, Diamond DM, Frackowiak R, Giedd J, Girault JA, Grace A, Lambert JJ, Manji H, Mayberg H, Popoli M, Prochiantz A, Richter-Levin G, Somogyi P, Spedding M, Svenningsson P, Weinberger D (2007) How can drug discovery for psychiatric disorders be improved? Nat Rev Drug Discov 6:189–201

    CAS  PubMed  Google Scholar 

  • Alexander A, Irving AJ, Harvey J (2017) Emerging roles for the novel estrogen-sensing receptor GPER1 in the CNS. Neuropharmacology 113:652–660

    CAS  PubMed  Google Scholar 

  • Altemus M, Sarvaiya N, Neill Epperson C (2014) Sex differences in anxiety and depression clinical perspectives. Front Neuroendocrinol 35(3):320–330

    PubMed  PubMed Central  Google Scholar 

  • Amsterdam J, Garcia-España F, Fawcett J, Quitkin F, Reimherr F, Rosenbaum J, Beasley C (1999) Fluoxetine efficacy in menopausal women with and without estrogen replacement. J Affect Disord 55:11–17

    CAS  PubMed  Google Scholar 

  • Anderson GD (2005) Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J Womens Health (Larchmt) 14(1):19–29

    PubMed  Google Scholar 

  • Andrews G, Bell C, Boyce P, Gale C, Lampe L, Marwat O, Rapee R, Wilkins G (2018) Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder. Aust N Z J Psychiatry 52(12):1109–1172

    Google Scholar 

  • Arevalo MA, Azcoitia I, Garcia-Segura LM (2015) The neuroprotective actions of oestradiol and oestrogen receptors. Nat Rev Neurosci 16:17–29

    CAS  PubMed  Google Scholar 

  • Atkinson HC, Waddell BJ (1997) Circadian variation in basal plasma corticosterone and adrenocorticotropin in the rat: sexual dimorphism and changes across the estrous cycle. Endocrinology 138(9):3842–3848

    CAS  PubMed  Google Scholar 

  • Balta G, Dalla C, Kokras N (2019) Women's psychiatry. Adv Exp Med Biol 1192:225–249

    CAS  PubMed  Google Scholar 

  • Bandelow B, Baldwin D, Abelli M, Bolea-Alamanac B, Bourin M, Chamberlain SR, Cinosi E, Davies S, Domschke K, Fineberg N, Grünblatt E, Jarema M, Kim YK, Maron E, Masdrakis V, Mikova O, Nutt D, Pallanti S, Pini S, Ströhle A, Thibaut F, Vaghi MM, Won E, Wedekind D, Wichniak A, Woolley J, Zwanzger P, Riederer P (2017) Biological markers for anxiety disorders, OCD and PTSD: a consensus statement. Part II: neurochemistry, neurophysiology and neurocognition. World J Biol Psychiatry 18(3):162–214

    PubMed  Google Scholar 

  • Bangasser DA, Curtis A, Reyes BA, Bethea TT, Parastatidis I, Ischiropoulos H, Van Bockstaele EJ, Valentino RJ (2010) Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol Psychiatry 15(9):877, 896–877, 904

    PubMed  Google Scholar 

  • Bangasser DA, Reyes BA, Piel D, Garachh V, Zhang XY, Plona ZM, Van Bockstaele EJ, Beck SG, Valentino RJ (2013) Increased vulnerability of the brain norepinephrine system of females to corticotropin-releasing factor overexpression. Mol Psychiatry 18(2):166–173

    CAS  PubMed  Google Scholar 

  • Berlanga C, Flores-Ramos M (2006) Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine. J Affect Disord 95:119–123

    CAS  PubMed  Google Scholar 

  • Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7(2):137–151

    CAS  PubMed  Google Scholar 

  • Bigos KL, Pollock BG, Stankevich BA, Bies RR (2009) Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: an updated review. Gend Med 6:522–543

    PubMed  Google Scholar 

  • Birur B, Amrock EM, Shelton RC, Li L (2017) Sex differences in the peripheral immune system in patients with depression. Front Psych 8:108

    Google Scholar 

  • Blanco C, Vesga-López O, Stewart JW, Liu SM, Grant BF, Hasin DS (2012) Epidemiology of major depression with atypical features: results from the national epidemiologic survey on alcohol and related conditions (NESARC). J Clin Psychiatry 73(2):224–232

    PubMed  Google Scholar 

  • Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR (2000) Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 157(6):924–930

    CAS  PubMed  Google Scholar 

  • Bloch M, Daly RC, Rubinow DR (2003) Endocrine factors in the etiology of postpartum depression. Compr Psychiatry 44:234–246

    PubMed  Google Scholar 

  • Bogetto F, Bellino S, Revello RB, Patria L (2002) Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation. CNS Drugs 16:273–283

    CAS  PubMed  Google Scholar 

  • Bollinger JL, Bergeon Burns CM, Wellman CL (2016) Differential effects of stress on microglial cell activation in male and female medial prefrontal cortex. Brain Behav Immun 52:88–97

    CAS  PubMed  Google Scholar 

  • Borrow AP, Cameron NM (2014) Estrogenic mediation of serotonergic and neurotrophic systems: implications for female mood disorders. Prog Neuropsychopharmacol Biol Psychiatry 54:13–25

    CAS  PubMed  Google Scholar 

  • Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, de Girolamo G, de Graaf R, Demyttenaere K, Hu C, Iwata N, Karam AN, Kaur J, Kostyuchenko S, Lépine JP, Levinson D, Matschinger H, Mora ME, Browne MO, Posada-Villa J, Viana MC, Williams DR, Kessler RC (2011) Cross-national epidemiology of DSM-IV major depressive episode. BMC Med 9:90

    PubMed  PubMed Central  Google Scholar 

  • Brotto LA, Chankasingh K, Baaske A, Albert A, Booth A, Kaida A, Smith LW, Racey S, Gottschlich A, Murray MCM, Sadarangani M, Ogilvie GS, Galea L (2021) The influence of sex, gender, age, and ethnicity on psychosocial factors and substance use throughout phases of the COVID-19 pandemic. PLoS One 16(11):e0259676

    CAS  PubMed  PubMed Central  Google Scholar 

  • Butlen-Ducuing F, Balkowiec-Iskra E, Dalla C, Slattery DA, Ferretti MT, Kokras N, Balabanov P, De Vries C, Mellino S, Santuccione Chadha A (2021) Implications of sex-related differences in central nervous system disorders for drug research and development. Nat Rev Drug Discov

    Google Scholar 

  • Calcia MA, Bonsall DR, Bloomfield PS, Selvaraj S, Barichello T, Howes OD (2016) Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness. Psychopharmacology (Berl) 233(9):1637–1650

    CAS  PubMed  Google Scholar 

  • Carrier N, Kabbaj M (2012) Extracellular signal-regulated kinase 2 signaling in the hippocampal dentate gyrus mediates the antidepressant effects of testosterone. Biol Psychiatry 71(7):642–651

    CAS  PubMed  PubMed Central  Google Scholar 

  • Carrier N, Kabbaj M (2013) Sex differences in the antidepressant-like effects of ketamine. Neuropharmacology 70:27–34

    CAS  PubMed  Google Scholar 

  • Chaiton JA, Wong SJ, Galea LA (2019) Chronic aromatase inhibition increases ventral hippocampal neurogenesis in middle-aged female mice. Psychoneuroendocrinology 106:111–116

    CAS  PubMed  Google Scholar 

  • Chang YJ, Yang CH, Liang YC, Yeh CM, Huang CC, Hsu KS (2009) Estrogen modulates sexually dimorphic contextual fear extinction in rats through estrogen receptor beta. Hippocampus 19(11):1142–1150

    CAS  PubMed  Google Scholar 

  • Clayton JA, Collins FS (2014) Policy: NIH to balance sex in cell and animal studies. Nature 509(7500):282–283

    PubMed  PubMed Central  Google Scholar 

  • Clayton AH, Croft HA, Handiwala L (2014) Antidepressants and sexual dysfunction: mechanisms and clinical implications. Postgrad Med 126(2):91–99

    PubMed  Google Scholar 

  • Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL (2006) Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 63:385–390

    PubMed  Google Scholar 

  • COVID-19 Mental Disorders Collaborators (2021) Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet 398(10312):1700–1712

    Google Scholar 

  • da Rocha JT, Pinton S, Mazzanti A, Mazzanti CM, Beckemann DV, Nogueira CW, Zeni G (2012) Diphenyl diselenide ameliorates cognitive deficits induced by a model of menopause in rats. Behav Pharmacol 23(1):98–104

    PubMed  Google Scholar 

  • Dalla C, Antoniou K, Kokras N, Drossopoulou G, Papathanasiou G, Bekris S, Daskas S, Papadopoulou-Daifoti Z (2008) Sex differences in the effects of two stress paradigms on dopaminergic neurotransmission. Physiol Behav 93:595–605

    CAS  PubMed  Google Scholar 

  • Dalla C, Pitychoutis PM, Kokras N, Papadopoulou-Daifoti Z (2010) Sex differences in animal models of depression and antidepressant response. Basic Clin Pharmacol Toxicol 106:226–233

    CAS  PubMed  Google Scholar 

  • Dantzer R, Kelley KW (2007) Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 21(2):153–160

    CAS  PubMed  Google Scholar 

  • David DJ, Nic Dhonnchadha BA, Jolliet P, Hascoët M, Bourin M (2001) Are there gender differences in the temperature profile of mice after acute antidepressant administration and exposure to two animal models of depression? Behav Brain Res 119:203–211

    CAS  PubMed  Google Scholar 

  • David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, Mendez I, Drew M, Craig DA, Guiard BP, Guilloux JP, Artymyshyn RP, Gardier AM, Gerald C, Antonijevic IA, Leonardo ED, Hen R (2009) Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 62(4):479–493

    CAS  PubMed  PubMed Central  Google Scholar 

  • de Wit AE, Giltay EJ, de Boer MK, Nathan M, Wiley A, Crawford S, Joffe H (2021) Predictors of irritability symptoms in mildly depressed perimenopausal women. Psychoneuroendocrinology 126:105128

    PubMed  Google Scholar 

  • Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, Bologa CG, Leitao A, Brailoiu E, Deliu E, Dun NJ, Sklar LA, Hathaway HJ, Arterburn JB, Oprea TI, Prossnitz ER (2009) In vivo effects of a GPR30 antagonist. Nat Chem Biol 5(6):421–427

    CAS  PubMed  PubMed Central  Google Scholar 

  • DiBlasio CJ, Hammett J, Malcolm JB, Judge BA, Womack JH, Kincade MC, Ogles ML, Mancini JG, Patterson AL, Wake RW, Derweesh IH (2008) Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer. Can J Urol 15(5):4249–4256. discussion 4256

    PubMed  Google Scholar 

  • Donner NC, Lowry CA (2013) Sex differences in anxiety and emotional behavior. Pflugers Arch 465(5):601–626

    CAS  PubMed  PubMed Central  Google Scholar 

  • Drici MD, Clément N (2001) Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome. Drug Saf 24(8):575–585

    CAS  PubMed  Google Scholar 

  • Duman RS (2018) Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide. F1000Res 7

    Google Scholar 

  • Duman RS, Aghajanian GK (2012) Synaptic dysfunction in depression: potential therapeutic targets. Science 338(6103):68–72

    CAS  PubMed  PubMed Central  Google Scholar 

  • Duman RS, Aghajanian GK, Sanacora G, Krystal JH (2016) Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med 22(3):238–249

    CAS  PubMed  PubMed Central  Google Scholar 

  • Eid RS, Gobinath AR, Galea LAM (2019) Sex differences in depression: insights from clinical and preclinical studies. Prog Neurobiol 176:86–102

    PubMed  Google Scholar 

  • Estrada-Camarena E, Fernández-Guasti A, López-Rubalcava C (2004) Interaction between estrogens and antidepressants in the forced swimming test in rats. Psychopharmacology (Berl) 173(1-2):139–145

    CAS  PubMed  Google Scholar 

  • Estrada-Camarena E, López-Rubalcava C, Vega-Rivera N, Récamier-Carballo S, Fernández-Guasti A (2010) Antidepressant effects of estrogens: a basic approximation. Behav Pharmacol 21(5–6):451–464

    CAS  PubMed  Google Scholar 

  • Fernández-Guasti A, Olivares-Nazario M, Reyes R, Martínez-Mota L (2017) Sex and age differences in the antidepressant-like effect of fluoxetine in the forced swim test. Pharmacol Biochem Behav 152:81–89

    PubMed  Google Scholar 

  • Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, Vos T, Whiteford HA (2013) Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med 10(11):e1001547

    PubMed  PubMed Central  Google Scholar 

  • Findikli E, Kurutas EB, Camkurt MA, Karaaslan MF, Izci F, Fındıklı HA, Kardaş S, Dag B, Altun H (2017) Increased serum G protein-coupled estrogen receptor 1 levels and its diagnostic value in drug naïve patients with major depressive disorder. Clin Psychopharmacol Neurosci 15(4):337–342

    CAS  PubMed  PubMed Central  Google Scholar 

  • Flint J, Kendler KS (2014) The genetics of major depression. Neuron 81(3):484–503

    CAS  PubMed  PubMed Central  Google Scholar 

  • Franceschelli A, Sens J, Herchick S, Thelen C, Pitychoutis PM (2015) Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and “depressed” mice exposed to chronic mild stress. Neuroscience 290:49–60

    CAS  PubMed  Google Scholar 

  • Frokjaer VG, Pinborg A, Holst KK, Overgaard A, Henningsson S, Heede M, Larsen EC, Jensen PS, Agn M, Nielsen AP, Stenbæk DS, da Cunha-Bang S, Lehel S, Siebner HR, Mikkelsen JD, Svarer C, Knudsen GM (2015) Role of serotonin transporter changes in depressive responses to sex-steroid hormone manipulation: a positron emission tomography study. Biol Psychiatry 78:534–543

    CAS  PubMed  Google Scholar 

  • Frye CA, Walf AA (2009) Depression-like behavior of aged male and female mice is ameliorated with administration of testosterone or its metabolites. Physiol Behav 97(2):266–269

    CAS  PubMed  PubMed Central  Google Scholar 

  • Frye CA, Koonce CJ, Edinger KL, Osborne DM, Walf AA (2008) Androgens with activity at estrogen receptor beta have anxiolytic and cognitive-enhancing effects in male rats and mice. Horm Behav 54(5):726–734

    CAS  PubMed  PubMed Central  Google Scholar 

  • Furuta M, Numakawa T, Chiba S, Ninomiya M, Kajiyama Y, Adachi N, Akema T, Kunugi H (2013) Estrogen, predominantly via estrogen receptor α, attenuates postpartum-induced anxiety- and depression-like behaviors in female rats. Endocrinology 154:3807–3816

    CAS  PubMed  Google Scholar 

  • Galvin C, Ninan I (2014) Regulation of the mouse medial prefrontal cortical synapses by endogenous estradiol. Neuropsychopharmacology 39(9):2086–2094

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ganguly P, Brenhouse HC (2015) Broken or maladaptive? Altered trajectories in neuroinflammation and behavior after early life adversity. Dev Cogn Neurosci 11:18–30

    PubMed  Google Scholar 

  • Goel N, Workman JL, Lee TT, Innala L, Viau V (2014) Sex differences in the HPA axis. Compr Physiol 4(3):1121–1155

    PubMed  Google Scholar 

  • Gold PW, Machado-Vieira R, Pavlatou MG (2015) Clinical and biochemical manifestations of depression: relation to the neurobiology of stress. Neural Plast 2015:581976

    PubMed  PubMed Central  Google Scholar 

  • Gómez ML, Martínez-Mota L, Estrada-Camarena E, Fernández-Guasti A (2014) Influence of the brain sexual differentiation process on despair and antidepressant-like effect of fluoxetine in the rat forced swim test. Neuroscience 261:11–22

    PubMed  Google Scholar 

  • Graham BM, Milad MR (2013) Blockade of estrogen by hormonal contraceptives impairs fear extinction in female rats and women. Biol Psychiatry 73(4):371–378

    CAS  PubMed  Google Scholar 

  • Guintivano J, Arad M, Gould TD, Payne JL, Kaminsky ZA (2014) Antenatal prediction of postpartum depression with blood DNA methylation biomarkers. Mol Psychiatry 19(5):560–567

    CAS  PubMed  Google Scholar 

  • Gutierrez-Rojas L, Porras-Segovia A, Dunne H, Andrade-Gonzalez N, Cervilla JA (2020) Prevalence and correlates of major depressive disorder: a systematic review. Braz J Psychiatry 42(6):657–672

    PubMed  PubMed Central  Google Scholar 

  • Halbreich U, Karkun S (2006) Cross-cultural and social diversity of prevalence of postpartum depression and depressive symptoms. J Affect Disord 91:97–111

    PubMed  Google Scholar 

  • Halbreich U, Borenstein J, Pearlstein T, Kahn LS (2003) The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 28(Suppl 3):1–23

    CAS  PubMed  Google Scholar 

  • Halbreich U, Backstrom T, Eriksson E, O'Brien S, Calil H, Ceskova E, Dennerstein L, Douki S, Freeman E, Genazzani A, Heuser I, Kadri N, Rapkin A, Steiner M, Wittchen HU, Yonkers K (2007) Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies. Gynecol Endocrinol 23:123–130

    PubMed  Google Scholar 

  • Hamidovic A, Karapetyan K, Serdarevic F, Choi SH, Eisenlohr-Moul T, Pinna G (2020) Higher circulating cortisol in the follicular vs. luteal phase of the menstrual cycle: a meta-analysis. Front Endocrinol (Lausanne) 11:311

    PubMed  Google Scholar 

  • Heidrich A, Schleyer M, Spingler H, Albert P, Knoche M, Fritze J, Lanczik M (1994) Postpartum blues: relationship between not-protein bound steroid hormones in plasma and postpartum mood changes. J Affect Disord 30:93–98

    CAS  PubMed  Google Scholar 

  • Hendrick V, Altshuler LL, Suri R (1998) Hormonal changes in the postpartum and implications for postpartum depression. Psychosomatics 39:93–101

    CAS  PubMed  Google Scholar 

  • Hodes GE, Pfau ML, Purushothaman I, Ahn HF, Golden SA, Christoffel DJ, Magida J, Brancato A, Takahashi A, Flanigan ME, Ménard C, Aleyasin H, Koo JW, Lorsch ZS, Feng J, Heshmati M, Wang M, Turecki G, Neve R, Zhang B, Shen L, Nestler EJ, Russo SJ (2015) Sex differences in nucleus accumbens transcriptome profiles associated with susceptibility versus resilience to subchronic variable stress. J Neurosci 35(50):16362–16376

    CAS  PubMed  PubMed Central  Google Scholar 

  • Hodes GE, Walker DM, Labonté B, Nestler EJ, Russo SJ (2017) Understanding the epigenetic basis of sex differences in depression. J Neurosci Res 95(1-2):692–702

    CAS  PubMed  PubMed Central  Google Scholar 

  • Hodosy J, Zelmanová D, Majzúnová M, Filová B, Malinová M, Ostatníková D, Celec P (2012) The anxiolytic effect of testosterone in the rat is mediated via the androgen receptor. Pharmacol Biochem Behav 102:191–195

    CAS  PubMed  Google Scholar 

  • Holbrook TL, Hoyt DB, Stein MB, Sieber WJ (2002) Gender differences in long-term posttraumatic stress disorder outcomes after major trauma: women are at higher risk of adverse outcomes than men. J Trauma 53(5):882–888

    PubMed  Google Scholar 

  • Hudson SP, Jacobson-Pick S, Anisman H (2014) Sex differences in behavior and pro-inflammatory cytokine mRNA expression following stressor exposure and re-exposure. Neuroscience 277:239–249

    CAS  PubMed  Google Scholar 

  • Hughes ZA, Liu F, Platt BJ, Dwyer JM, Pulicicchio CM, Zhang G, Schechter LE, Rosenzweig-Lipson S, Day M (2008) WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent. Neuropharmacology 54:1136–1142

    CAS  PubMed  Google Scholar 

  • Hutson WR, Roehrkasse RL, Wald A (1989) Influence of gender and menopause on gastric emptying and motility. Gastroenterology 96:11–17

    CAS  PubMed  Google Scholar 

  • Hyde CL, Nagle MW, Tian C, Chen X, Paciga SA, Wendland JR, Tung JY, Hinds DA, Perlis RH, Winslow AR (2016) Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. Nat Genet 48(9):1031–1036

    CAS  PubMed  PubMed Central  Google Scholar 

  • Italia M, Forastieri C, Longaretti A, Battaglioli E, Rusconi F (2020) Rationale, relevance, and limits of stress-induced psychopathology in rodents as models for psychiatry research: an introductory overview. Int J Mol Sci 21(20)

    Google Scholar 

  • Jovicic MJ, Lukic I, Radojcic M, Adzic M, Maric NP (2015) Modulation of c-Jun N-terminal kinase signaling and specific glucocorticoid receptor phosphorylation in the treatment of major depression. Med Hypotheses 85(3):291–294

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kando JC, Yonkers KA, Cole JO (1995) Gender as a risk factor for adverse events to medications. Drugs 50(1):1–6

    CAS  PubMed  Google Scholar 

  • Kang HJ, Voleti B, Hajszan T, Rajkowska G, Stockmeier CA, Licznerski P, Lepack A, Majik MS, Jeong LS, Banasr M, Son H, Duman RS (2012) Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nat Med 18(9):1413–1417

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kastenberger I, Schwarzer C (2014) GPER1 (GPR30) knockout mice display reduced anxiety and altered stress response in a sex and paradigm dependent manner. Horm Behav 66(4):628–636

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kastenberger I, Lutsch C, Schwarzer C (2012) Activation of the G-protein-coupled receptor GPR30 induces anxiogenic effects in mice, similar to oestradiol. Psychopharmacology (Berl) 221(3):527–535

    CAS  PubMed  Google Scholar 

  • Kaur U, Pathak BK, Singh A, Chakrabarti SS (2021) Esketamine: a glimmer of hope in treatment-resistant depression. Eur Arch Psychiatry Clin Neurosci 271:417–429

    PubMed  Google Scholar 

  • Keating C, Tilbrook A, Kulkarni J (2011) Oestrogen: an overlooked mediator in the neuropsychopharmacology of treatment response? Int J Neuropsychopharmacol 14:553–566

    CAS  PubMed  Google Scholar 

  • Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51(1):8–19

    CAS  PubMed  Google Scholar 

  • Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62(6):617–627

    PubMed  PubMed Central  Google Scholar 

  • Kessler RC, Aguilar-Gaxiola S, Alonso J, Chatterji S, Lee S, Ormel J, Ustün TB, Wang PS (2009) The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiol Psichiatr Soc 18(1):23–33

    PubMed  PubMed Central  Google Scholar 

  • Kettenmann H, Kirchhoff F, Verkhratsky A (2013) Microglia: new roles for the synaptic stripper. Neuron 77:10–18

    CAS  PubMed  Google Scholar 

  • Khan A, Brodhead AE, Schwartz KA, Kolts RL, Brown WA (2005) Sex differences in antidepressant response in recent antidepressant clinical trials. J Clin Psychopharmacol 25:318–324

    PubMed  Google Scholar 

  • Kokras N, Dalla C (2014) Sex differences in animal models of psychiatric disorders. Br J Pharmacol 171(20):4595–4619

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kokras N, Dalla C (2017) Preclinical sex differences in depression and antidepressant response: Implications for clinical research. J Neurosci Res 95(1–2):731–736

    CAS  PubMed  Google Scholar 

  • Kokras N, Antoniou K, Dalla C, Bekris S, Xagoraris M, Ovestreet DH, Papadopoulou-Daifoti Z (2009) Sex-related differential response to clomipramine treatment in a rat model of depression. J Psychopharmacol 23:945–956

    CAS  PubMed  Google Scholar 

  • Kokras N, Dalla C, Papadopoulou-Daifoti Z (2011) Sex differences in pharmacokinetics of antidepressants. Expert Opin Drug Metab Toxicol 7(2):213–226

    PubMed  Google Scholar 

  • Kokras N, Dalla C, Sideris AC, Dendi A, Mikail HG, Antoniou K, Papadopoulou-Daifoti Z (2012) Behavioral sexual dimorphism in models of anxiety and depression due to changes in HPA axis activity. Neuropharmacology 62:436–445

    CAS  PubMed  Google Scholar 

  • Kokras N, Pastromas N, Porto TH, Kafetzopoulos V, Mavridis T, Dalla C (2014) Acute but not sustained aromatase inhibition displays antidepressant properties. Int J Neuropsychopharmacol 17:1307–1313

    CAS  PubMed  Google Scholar 

  • Kokras N, Antoniou K, Mikail HG, Kafetzopoulos V, Papadopoulou-Daifoti Z, Dalla C (2015) Forced swim test: what about females? Neuropharmacology 99:408–421

    CAS  PubMed  Google Scholar 

  • Kokras N, Pastromas N, Papasava D, de Bournonville C, Cornil CA, Dalla C (2018a) Sex differences in behavioral and neurochemical effects of gonadectomy and aromatase inhibition in rats. Psychoneuroendocrinology 87:93–107

    CAS  PubMed  Google Scholar 

  • Kokras N, Stamouli E, Sotiropoulos I, Katirtzoglou EA, Siarkos KT, Dalagiorgou G, Alexandraki KI, Coulocheri S, Piperi C, Politis AM (2018b) Acetyl cholinesterase inhibitors and cell-derived peripheral inflammatory cytokines in early stages of Alzheimer's disease. J Clin Psychopharmacol 38(2):138–143

    CAS  PubMed  Google Scholar 

  • Kokras N, Hodes GE, Bangasser DA, Dalla C (2019) Sex differences in the hypothalamic-pituitary-adrenal axis: an obstacle to antidepressant drug development? Br J Pharmacol 176(21):4090–4106

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kokras N, Krokida S, Varoudaki TZ, Dalla C (2021) Do corticosterone levels predict female depressive-like behavior in rodents? J Neurosci Res 99(1):324–331

    CAS  PubMed  Google Scholar 

  • Kornstein SG (1997) Gender differences in depression: implications for treatment. J Clin Psychiatry 58(Suppl 15):12–18

    PubMed  Google Scholar 

  • Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Davis SM, Harrison WM, Keller MB (2000) Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 157(9):1445–1452

    CAS  PubMed  Google Scholar 

  • Kornstein SG, Pedersen RD, Holland PJ, Nemeroff CB, Rothschild AJ, Thase ME, Trivedi MH, Ninan PT, Keller MB (2014) Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the PREVENT study. J Clin Psychiatry 75(1):62–68

    PubMed  Google Scholar 

  • Kreisel T, Frank MG, Licht T, Reshef R, Ben-Menachem-Zidon O, Baratta MV, Maier SF, Yirmiya R (2014) Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. Mol Psychiatry 19:699–709

    CAS  PubMed  Google Scholar 

  • Kreutzberg GW (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312–318

    CAS  PubMed  Google Scholar 

  • Kristensen CB (1983) Imipramine serum protein binding in healthy subjects. Clin Pharmacol Ther 34:689–694

    CAS  PubMed  Google Scholar 

  • Kuehner C (2017) Why is depression more common among women than among men? Lancet Psychiatry 4:146–158

    PubMed  Google Scholar 

  • Kyratsas C, Dalla C, Anderzhanova E, Polissidis A, Kokras N, Konstantinides K, Papadopoulou-Daifoti Z (2013) Experimental evidence for sildenafil's action in the central nervous system: dopamine and serotonin changes in the medial preoptic area and nucleus accumbens during sexual arousal. J Sex Med 10(3):719–729

    CAS  PubMed  Google Scholar 

  • Labaka A, Goñi-Balentziaga O, Lebeña A, Pérez-Tejada J (2018) Biological sex differences in depression: a systematic review. Biol Res Nurs 20(4):383–392

    PubMed  Google Scholar 

  • Labonté B, Engmann O, Purushothaman I, Menard C, Wang J, Tan C, Scarpa JR, Moy G, Loh YE, Cahill M, Lorsch ZS, Hamilton PJ, Calipari ES, Hodes GE, Issler O, Kronman H, Pfau M, Obradovic ALJ, Dong Y, Neve RL, Russo S, Kazarskis A, Tamminga C, Mechawar N, Turecki G, Zhang B, Shen L, Nestler EJ (2017) Sex-specific transcriptional signatures in human depression. Nat Med 23(9):1102–1111

    PubMed  PubMed Central  Google Scholar 

  • LeMoult J, Chen MC, Foland-Ross LC, Burley HW, Gotlib IH (2015) Concordance of mother-daughter diurnal cortisol production: understanding the intergenerational transmission of risk for depression. Biol Psychol 108:98–104

    PubMed  PubMed Central  Google Scholar 

  • Levey DF, Stein MB, Wendt FR, Pathak GA, Zhou H, Aslan M, Quaden R, Harrington KM, Nuñez YZ, Overstreet C, Radhakrishnan K, Sanacora G, McIntosh AM, Shi J, Shringarpure SS, Concato J, Polimanti R, Gelernter J (2021) Bi-ancestral depression GWAS in the Million Veteran Program and meta-analysis in >1.2 million individuals highlight new therapeutic directions. Nat Neurosci 24(7):954–963

    CAS  PubMed  PubMed Central  Google Scholar 

  • Li N, Liu RJ, Dwyer JM, Banasr M, Lee B, Son H, Li XY, Aghajanian G, Duman RS (2011) Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry 69(8):754–761

    CAS  PubMed  PubMed Central  Google Scholar 

  • Lijster JM, Dierckx B, Utens EM, Verhulst FC, Zieldorff C, Dieleman GC, Legerstee JS (2017) The age of onset of anxiety disorders. Can J Psychiatry 62(4):237–246

    PubMed  Google Scholar 

  • Lim GY, Tam WW, Lu Y, Ho CS, Zhang MW, Ho RC (2018) Prevalence of depression in the community from 30 countries between 1994 and 2014. Sci Rep 8(1):2861

    PubMed  PubMed Central  Google Scholar 

  • Lorenz T, Rullo J, Faubion S (2016) Antidepressant-induced female sexual dysfunction. Mayo Clin Proc 91(9):1280–1286

    CAS  PubMed  Google Scholar 

  • Maeng LY, Milad MR (2015) Sex differences in anxiety disorders: interactions between fear, stress, and gonadal hormones. Horm Behav 76:106–117

    CAS  PubMed  PubMed Central  Google Scholar 

  • Mahmoud R, Wainwright SR, Chaiton JA, Lieblich SE, Galea LAM (2016) Ovarian hormones, but not fluoxetine, impart resilience within a chronic unpredictable stress model in middle-aged female rats. Neuropharmacology 107:278–293

    CAS  PubMed  Google Scholar 

  • Maki PM, Kornstein SG, Joffe H, Bromberger JT, Freeman EW, Athappilly G, Bobo WV, Rubin LH, Koleva HK, Cohen LS, Soares CN (2018) Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause 25(10):1069–1085

    PubMed  Google Scholar 

  • Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH (1993) Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 270(21):2590–2597

    CAS  PubMed  Google Scholar 

  • Marazziti D, Baroni S, Picchetti M, Piccinni A, Carlini M, Vatteroni E, Falaschi V, Lombardi A, Dell'Osso L (2013) Pharmacokinetics and pharmacodynamics of psychotropic drugs: effect of sex. CNS Spectr 18:118–127

    PubMed  Google Scholar 

  • Marcus SM, Young EA, Kerber KB, Kornstein S, Farabaugh AH, Mitchell J, Wisniewski SR, Balasubramani GK, Trivedi MH, Rush AJ (2005) Gender differences in depression: findings from the STAR*D study. J Affect Disord 87:141–150

    PubMed  Google Scholar 

  • McDermott CM, Liu D, Schrader LA (2012) Role of gonadal hormones in anxiety and fear memory formation and inhibition in male mice. Physiol Behav 105:1168–1174

    CAS  PubMed  Google Scholar 

  • McHenry J, Carrier N, Hull E, Kabbaj M (2014) Sex differences in anxiety and depression: role of testosterone. Front Neuroendocrinol 35(1):42–57

    CAS  PubMed  Google Scholar 

  • McLean CP, Asnaani A, Litz BT, Hofmann SG (2011) Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness. J Psychiatr Res 45(8):1027–1035

    PubMed  PubMed Central  Google Scholar 

  • Meibohm B, Beierle I, Derendorf H (2002) How important are gender differences in pharmacokinetics? Clin Pharmacokinet 41:329–342

    CAS  PubMed  Google Scholar 

  • Mikail HG, Dalla C, Kokras N, Kafetzopoulos V, Papadopoulou-Daifoti Z (2012) Sertraline behavioral response associates closer and dose-dependently with cortical rather than hippocampal serotonergic activity in the rat forced swim stress. Physiol Behav 107:201–206

    CAS  PubMed  Google Scholar 

  • Milad MR, Igoe SA, Lebron-Milad K, Novales JE (2009) Estrous cycle phase and gonadal hormones influence conditioned fear extinction. Neuroscience 164(3):887–895

    CAS  PubMed  Google Scholar 

  • Miller AH, Raison CL (2016) The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 16(1):22–34

    CAS  PubMed  PubMed Central  Google Scholar 

  • Miller LR, Marks C, Becker JB, Hurn PD, Chen WJ, Woodruff T, McCarthy MM, Sohrabji F, Schiebinger L, Wetherington CL, Makris S, Arnold AP, Einstein G, Miller VM, Sandberg K, Maier S, Cornelison TL, Clayton JA (2017) Considering sex as a biological variable in preclinical research. FASEB J 31(1):29–34

    CAS  PubMed  Google Scholar 

  • Mitsushima D, Masuda J, Kimura F (2003) Sex differences in the stress-induced release of acetylcholine in the hippocampus and corticosterone from the adrenal cortex in rats. Neuroendocrinology 78:234–240

    CAS  PubMed  Google Scholar 

  • Moieni M, Irwin MR, Jevtic I, Olmstead R, Breen EC, Eisenberger NI (2015) Sex differences in depressive and socioemotional responses to an inflammatory challenge: implications for sex differences in depression. Neuropsychopharmacology 40(7):1709–1716

    CAS  PubMed  PubMed Central  Google Scholar 

  • Montejo-González AL, Llorca G, Izquierdo JA, Ledesma A, Bousoño M, Calcedo A, Carrasco JL, Ciudad J, Daniel E, De la Gandara J, Derecho J, Franco M, Gomez MJ, Macias JA, Martin T, Perez V, Sanchez JM, Sanchez S, Vicens E (1997) SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 23(3):176–194

    PubMed  Google Scholar 

  • Morgan MA, Pfaff DW (2001) Effects of estrogen on activity and fear-related behaviors in mice. Horm Behav 40:472–482

    CAS  PubMed  Google Scholar 

  • Morrison MF, Ten Have T, Freeman EW, Sammel MD, Grisso JA (2001) DHEA-S levels and depressive symptoms in a cohort of African American and Caucasian women in the late reproductive years. Biol Psychiatry 50:705–711

    CAS  PubMed  Google Scholar 

  • Naito S, Sato K, Yoshida K, Higuchi H, Takahashi H, Kamata M, Ito K, Ohkubo T, Shimizu T (2007) Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patients. Psychiatry Clin Neurosci 61:421–427

    CAS  PubMed  Google Scholar 

  • National Collaborating Centre for Mental Health (UK) (2010) Depression: the treatment and management of depression in adults (updated edition). British Psychological Society, Leicester

    Google Scholar 

  • Nestler EJ (2014) Epigenetic mechanisms of depression. JAMA Psychiat 71(4):454–456

    Google Scholar 

  • Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM (2002) Neurobiology of depression. Neuron 34:13–25

    CAS  PubMed  Google Scholar 

  • Nicolas JM, Espie P, Molimard M (2009) Gender and interindividual variability in pharmacokinetics. Drug Metab Rev 41(3):408–421

    CAS  PubMed  Google Scholar 

  • Nicolson TJ, Mellor HR, Roberts RR (2010) Gender differences in drug toxicity. Trends Pharmacol Sci 31:108–114

    CAS  PubMed  Google Scholar 

  • O'Hara MW, Schlechte JA, Lewis DA, Wright EJ (1991) Prospective study of postpartum blues. Biologic and psychosocial factors. Arch Gen Psychiatry 48(9):801–806

    CAS  PubMed  Google Scholar 

  • O'Leary OF, Dinan TG, Cryan JF (2015) Faster, better, stronger: towards new antidepressant therapeutic strategies. Eur J Pharmacol 753:32–50

    CAS  PubMed  Google Scholar 

  • Olivier JD, Olivier B (2019) Antidepressants and sexual dysfunctions: a translational perspective. Curr Sex Health Rep 11(3):156–166

    Google Scholar 

  • Parker G, Parker K, Austin MP, Mitchell P, Brotchie H (2003) Gender differences in response to differing antidepressant drug classes: two negative studies. Psychol Med 33(8):1473–1477

    CAS  PubMed  Google Scholar 

  • Pavlidi P, Kokras N, Dalla C (2021) Antidepressants’ effects on testosterone and estrogens: what do we know? Eur J Pharmacol 899:173998

    CAS  PubMed  Google Scholar 

  • Pawluski JL, Kokras N, Charlier TD, Dalla C (2020) Sex matters in neuroscience and neuropsychopharmacology. Eur J Neurosci 52(1):2423–2428

    PubMed  Google Scholar 

  • Peeters F, Nicholson NA, Berkhof J (2003) Cortisol responses to daily events in major depressive disorder. Psychosom Med 65(5):836–841

    CAS  PubMed  Google Scholar 

  • Penninx BW, Milaneschi Y, Lamers F, Vogelzangs N (2013) Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med 11:129

    PubMed  PubMed Central  Google Scholar 

  • Pitychoutis PM, Nakamura K, Tsonis PA, Papadopoulou-Daifoti Z (2009) Neurochemical and behavioral alterations in an inflammatory model of depression: sex differences exposed. Neuroscience 159:1216–1232

    CAS  PubMed  Google Scholar 

  • Pitychoutis PM, Zisaki A, Dalla C, Papadopoulou-Daifoti Z (2010) Pharmacogenetic insights into depression and antidepressant response: does sex matter? Curr Pharm Des 16:2214–2223

    CAS  PubMed  Google Scholar 

  • Rainville JR, Tsyglakova M, Hodes GE (2018) Deciphering sex differences in the immune system and depression. Front Neuroendocrinol 50:67–90

    CAS  PubMed  Google Scholar 

  • Randesi M, Zhou Y, Mazid S, Odell SC, Gray JD, Correa da Rosa J, McEwen BS, Milner TA, Kreek MJ (2018) Sex differences after chronic stress in the expression of opioid-, stress- and neuroplasticity-related genes in the rat hippocampus. Neurobiol Stress 8:33–41

    PubMed  PubMed Central  Google Scholar 

  • Remus JL, Dantzer R (2016) Inflammation models of depression in rodents: relevance to psychotropic drug discovery. Int J Neuropsychopharmacol 19(9)

    Google Scholar 

  • Rey CD, Lipps J, Shansky RM (2014) Dopamine D1 receptor activation rescues extinction impairments in low-estrogen female rats and induces cortical layer-specific activation changes in prefrontal-amygdala circuits. Neuropsychopharmacology 39(5):1282–1289

    CAS  PubMed  PubMed Central  Google Scholar 

  • Richardson TA, Robinson RD (2000) Menopause and depression: a review of psychologic function and sex steroid neurobiology during the menopause(1). Prim Care Update Ob Gyns 7:215–223

    CAS  PubMed  Google Scholar 

  • Roca CA, Schmidt PJ, Altemus M, Deuster P, Danaceau MA, Putnam K, Rubinow DR (2003) Differential menstrual cycle regulation of hypothalamic-pituitary-adrenal axis in women with premenstrual syndrome and controls. J Clin Endocrinol Metab 88(7):3057–3063

    CAS  PubMed  Google Scholar 

  • Rubinow DR, Schmidt PJ (2019) Sex differences and the neurobiology of affective disorders. Neuropsychopharmacology 44(1):111–128

    PubMed  Google Scholar 

  • Ryan J, Scali J, Carrière I, Peres K, Rouaud O, Scarabin PY, Ritchie K, Ancelin ML (2011) Oestrogen receptor polymorphisms and late-life depression. Br J Psychiatry 199(2):126–131

    PubMed  PubMed Central  Google Scholar 

  • Saland SK, Duclot F, Kabbaj M (2017) Integrative analysis of sex differences in the rapid antidepressant effects of ketamine in preclinical models for individualized clinical outcomes. Curr Opin Behav Sci 14:19–26

    PubMed  Google Scholar 

  • Sarginson JE, Lazzeroni LC, Ryan HS, Ershoff BD, Schatzberg AF, Murphy GM Jr (2010) ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression. Pharmacogenet Genomics 20(8):467–475

    CAS  PubMed  Google Scholar 

  • Sarkar A, Kabbaj M (2016) Sex differences in effects of ketamine on behavior, spine density, and synaptic proteins in socially isolated rats. Biol Psychiatry 80(6):448–456

    CAS  PubMed  PubMed Central  Google Scholar 

  • Schmalenberger KM, Tauseef HA, Barone JC, Owens SA, Lieberman L, Jarczok MN, Girdler SS, Kiesner J, Ditzen B, Eisenlohr-Moul TA (2021) How to study the menstrual cycle: practical tools and recommendations. Psychoneuroendocrinology 123:104895

    PubMed  Google Scholar 

  • Schmidt PJ (2005) Mood, depression, and reproductive hormones in the menopausal transition. Am J Med 118(Suppl 12B):54–58

    PubMed  Google Scholar 

  • Schneider LS, Small GW, Hamilton SH, Bystritsky A, Nemeroff CB, Meyers BS (1997) Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. Am J Geriatr Psychiatry 5:97–106

    CAS  PubMed  Google Scholar 

  • Schneider LS, Small GW, Clary CM (2001) Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. Am J Geriatr Psychiatry 9:393–399

    CAS  PubMed  Google Scholar 

  • Schuch JJ, Roest AM, Nolen WA, Penninx BW, de Jonge P (2014) Gender differences in major depressive disorder: results from the Netherlands study of depression and anxiety. J Affect Disord 156:156–163

    PubMed  Google Scholar 

  • Schwartz JB (2007) The current state of knowledge on age, sex, and their interactions on clinical pharmacology. Clin Pharmacol Ther 82:87–96

    CAS  PubMed  Google Scholar 

  • Schwarz JM, Bilbo SD (2012) Sex, glia, and development: interactions in health and disease. Horm Behav 62(3):243–253

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sellers K, Raval P, Srivastava DP (2015) Molecular signature of rapid estrogen regulation of synaptic connectivity and cognition. Front Neuroendocrinol 36:72–89

    CAS  PubMed  Google Scholar 

  • Seney ML, Huo Z, Cahill K, French L, Puralewski R, Zhang J, Logan RW, Tseng G, Lewis DA, Sibille E (2018) Opposite molecular signatures of depression in men and women. Biol Psychiatry 84(1):18–27

    CAS  PubMed  PubMed Central  Google Scholar 

  • Seney ML, Glausier J, Sibille E (2022) Large-scale transcriptomics studies provide insight into sex differences in depression. Biol Psychiatry 91(1):14–24

    CAS  PubMed  Google Scholar 

  • Sens J, Schneider E, Mauch J, Schaffstein A, Mohamed S, Fasoli K, Saurine J, Britzolaki A, Thelen C, Pitychoutis PM (2017) Lipopolysaccharide administration induces sex-dependent behavioural and serotonergic neurochemical signatures in mice. Pharmacol Biochem Behav 153:168–181

    CAS  PubMed  Google Scholar 

  • Shansky RM (2019) Are hormones a “female problem” for animal research? Science 364:825–826

    CAS  PubMed  Google Scholar 

  • Shapira B, Oppenheim G, Zohar J, Segal M, Malach D, Belmaker RH (1985) Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives. Biol Psychiatry 20:576–579

    CAS  PubMed  Google Scholar 

  • Shores MM, Sloan KL, Matsumoto AM, Moceri VM, Felker B, Kivlahan DR (2004) Increased incidence of diagnosed depressive illness in hypogonadal older men. Arch Gen Psychiatry 61:162–167

    PubMed  Google Scholar 

  • Soares CN (2014) Mood disorders in midlife women: understanding the critical window and its clinical implications. Menopause 21(2):198–206

    PubMed  Google Scholar 

  • Soares CN, Almeida OP, Joffe H, Cohen LS (2001) Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 58:529–534

    CAS  PubMed  Google Scholar 

  • Sramek JJ, Murphy MF, Cutler NR (2016) Sex differences in the psychopharmacological treatment of depression. Dialogues Clin Neurosci 18(4):447–457

    PubMed  PubMed Central  Google Scholar 

  • Srivastava DP, Woolfrey KM, Penzes P (2013) Insights into rapid modulation of neuroplasticity by brain estrogens. Pharmacol Rev 65(4):1318–1350

    CAS  PubMed  PubMed Central  Google Scholar 

  • Stahl SM (1998) Basic psychopharmacology of antidepressants, part 2: estrogen as an adjunct to antidepressant treatment. J Clin Psychiatry 59(Suppl 4):15–24

    CAS  PubMed  Google Scholar 

  • Tang H, Zhang Q, Yang L, Dong Y, Khan M, Yang F, Brann DW, Wang R (2014) GPR30 mediates estrogen rapid signaling and neuroprotection. Mol Cell Endocrinol 387(1-2):52–58

    CAS  PubMed  PubMed Central  Google Scholar 

  • Thase ME, Entsuah R, Cantillon M, Kornstein SG (2005) Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions. J Womens Health (Larchmt) 14(7):609–616

    PubMed  Google Scholar 

  • Thibaut F (2017) Anxiety disorders: a review of current literature. Dialogues Clin Neurosci 19(2):87–88

    PubMed  PubMed Central  Google Scholar 

  • Tolin DF, Foa EB (2006) Sex differences in trauma and posttraumatic stress disorder: a quantitative review of 25 years of research. Psychol Bull 132:959–992

    PubMed  Google Scholar 

  • Tripp A, Oh H, Guilloux JP, Martinowich K, Lewis DA, Sibille E (2012) Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder. Am J Psychiatry 169(11):1194–1202

    PubMed  PubMed Central  Google Scholar 

  • Tsyglakova M, McDaniel D, Hodes GE (2019) Immune mechanisms of stress susceptibility and resilience: lessons from animal models. Front Neuroendocrinol 54:100771

    CAS  PubMed  Google Scholar 

  • Uhr M, Grauer MT, Yassouridis A, Ebinger M (2007) Blood-brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls. J Psychiatr Res 41:179–188

    PubMed  Google Scholar 

  • Vrtačnik P, Ostanek B, Mencej-Bedrač S, Marc J (2014) The many faces of estrogen signaling. Biochem Med (Zagreb) 24(3):329–342

    PubMed  Google Scholar 

  • Wainwright SR, Galea LA (2013) The neural plasticity theory of depression: assessing the roles of adult neurogenesis and PSA-NCAM within the hippocampus. Neural Plast 2013:805497

    PubMed  PubMed Central  Google Scholar 

  • Wainwright SR, Workman JL, Tehrani A, Hamson DK, Chow C, Lieblich SE, Galea LA (2016) Testosterone has antidepressant-like efficacy and facilitates imipramine-induced neuroplasticity in male rats exposed to chronic unpredictable stress. Horm Behav 79:58–69

    CAS  PubMed  Google Scholar 

  • Walf AA, Rhodes ME, Frye CA (2004) Antidepressant effects of ERbeta-selective estrogen receptor modulators in the forced swim test. Pharmacol Biochem Behav 78:523–529

    CAS  PubMed  Google Scholar 

  • Wang W, Wang GZ (2019) Understanding molecular mechanisms of the brain through transcriptomics. Front Physiol 10:214

    PubMed  PubMed Central  Google Scholar 

  • Wang ZF, Pan ZY, Xu CS, Li ZQ (2017) Activation of G-protein coupled estrogen receptor 1 improves early-onset cognitive impairment via PI3K/Akt pathway in rats with traumatic brain injury. Biochem Biophys Res Commun 482:948–953

    CAS  PubMed  Google Scholar 

  • Wang J, Li HY, Shen SY, Zhang JR, Liang LF, Huang HJ, Li B, Wu GC, Zhang YQ, Yu J (2021) The antidepressant and anxiolytic effect of GPER on translocator protein (TSPO) via protein kinase a (PKA) signaling in menopausal female rats. J Steroid Biochem Mol Biol 207:105807

    CAS  PubMed  Google Scholar 

  • Waxman DJ, Holloway MG (2009) Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol 76(2):215–228

    CAS  PubMed  PubMed Central  Google Scholar 

  • Weinstock M, Razin M, Schorer-Apelbaum D, Men D, McCarty R (1998) Gender differences in sympathoadrenal activity in rats at rest and in response to footshock stress. Int J Dev Neurosci 16:289–295

    CAS  PubMed  Google Scholar 

  • Weissman MM, Klerman GL (1977) Sex differences and the epidemiology of depression. Arch Gen Psychiatry 34(1):98–111

    CAS  PubMed  Google Scholar 

  • Westley CJ, Amdur RL, Irwig MS (2015) High rates of depression and depressive symptoms among men referred for borderline testosterone levels. J Sex Med 12:1753–1760

    CAS  PubMed  Google Scholar 

  • Wieland S, Fischette CT, Lucki I (1993) Effect of chronic treatments with tandospirone and imipramine on serotonin-mediated behavioral responses and monoamine receptors. Neuropharmacology 32(6):561–573

    CAS  PubMed  Google Scholar 

  • Williams AV, Trainor BC (2018) The impact of sex as a biological variable in the search for novel antidepressants. Front Neuroendocrinol 50:107–117

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wong ML, Licinio J (2001) Research and treatment approaches to depression. Nat Rev Neurosci 2:343–351

    CAS  PubMed  Google Scholar 

  • Woods NF, Smith-DiJulio K, Percival DB, Tao EY, Mariella A, Mitchell S (2008) Depressed mood during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women’s Health Study. Menopause 15(2):223–232

    PubMed  Google Scholar 

  • Wray NR, Ripke S, Mattheisen M, Trzaskowski M, Byrne EM, Abdellaoui A, Adams MJ, Agerbo E, Air TM, Andlauer TMF, Bacanu SA, Bækvad-Hansen M, Beekman AFT, Bigdeli TB, Binder EB, Blackwood DRH, Bryois J, Buttenschøn HN, Bybjerg-Grauholm J, Cai N, Castelao E, Christensen JH, Clarke TK, Coleman JIR, Colodro-Conde L, Couvy-Duchesne B, Craddock N, Crawford GE, Crowley CA, Dashti HS, Davies G, Deary IJ, Degenhardt F, Derks EM, Direk N, Dolan CV, Dunn EC, Eley TC, Eriksson N, Escott-Price V, Kiadeh FHF, Finucane HK, Forstner AJ, Frank J, Gaspar HA, Gill M, Giusti-Rodríguez P, Goes FS, Gordon SD, Grove J, Hall LS, Hannon E, Hansen CS, Hansen TF, Herms S, Hickie IB, Hoffmann P, Homuth G, Horn C, Hottenga JJ, Hougaard DM, Hu M, Hyde CL, Ising M, Jansen R, Jin F, Jorgenson E, Knowles JA, Kohane IS, Kraft J, Kretzschmar WW, Krogh J, Kutalik Z, Lane JM, Li Y, Lind PA, Liu X, Lu L, MacIntyre DJ, MacKinnon DF, Maier RM, Maier W, Marchini J, Mbarek H, McGrath P, McGuffin P, Medland SE, Mehta D, Middeldorp CM, Mihailov E, Milaneschi Y, Milani L, Mill J, Mondimore FM, Montgomery GW, Mostafavi S, Mullins N, Nauck M, Ng B, Nivard MG, Nyholt DR, O'Reilly PF, Oskarsson H, Owen MJ, Painter JN, Pedersen CB, Pedersen MG, Peterson RE, Pettersson E, Peyrot WJ, Pistis G, Posthuma D, Purcell SM, Quiroz JA, Qvist P, Rice JP, Riley BP, Rivera M, Saeed Mirza S, Saxena R, Schoevers R, Schulte EC, Shen L, Shi J, Shyn SI, Sigurdsson E, Sinnamon GBC, Smit JH, Smith DJ, Stefansson H, Steinberg S, Stockmeier CA, Streit F, Strohmaier J, Tansey KE, Teismann H, Teumer A, Thompson W, Thomson PA, Thorgeirsson TE, Tian C, Traylor M, Treutlein J, Trubetskoy V, Uitterlinden AG, Umbricht D, Van der Auwera S, van Hemert AM, Viktorin A, Visscher PM, Wang Y, Webb BT, Weinsheimer SM, Wellmann J, Willemsen G, Witt SH, Wu Y, Xi HS, Yang J, Zhang F, Arolt V, Baune BT, Berger K, Boomsma DI, Cichon S, Dannlowski U, de Geus ECJ, DePaulo JR, Domenici E, Domschke K, Esko T, Grabe HJ, Hamilton SP, Hayward C, Heath AC, Hinds DA, Kendler KS, Kloiber S, Lewis G, Li QS, Lucae S, Madden PFA, Magnusson PK, Martin NG, McIntosh AM, Metspalu A, Mors O, Mortensen PB, Müller-Myhsok B, Nordentoft M, Nöthen MM, O'Donovan MC, Paciga SA, Pedersen NL, Penninx B, Perlis RH, Porteous DJ, Potash JB, Preisig M, Rietschel M, Schaefer C, Schulze TG, Smoller JW, Stefansson K, Tiemeier H, Uher R, Völzke H, Weissman MM, Werge T, Winslow AR, Lewis CM, Levinson DF, Breen G, Børglum AD, Sullivan PF (2018) Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet 50(5):668–681

    CAS  PubMed  PubMed Central  Google Scholar 

  • Young EA, Breslau N (2004) Cortisol and catecholamines in posttraumatic stress disorder: an epidemiologic community study. Arch Gen Psychiatry 61(4):394–401

    CAS  PubMed  Google Scholar 

  • Young EA, Carlson NE, Brown MB (2001) Twenty-four-hour ACTH and cortisol pulsatility in depressed women. Neuropsychopharmacology 25(2):267–276

    CAS  PubMed  Google Scholar 

  • Young EA, Kornstein SG, Marcus SM, Harvey AT, Warden D, Wisniewski SR, Balasubramani GK, Fava M, Trivedi MH, John Rush A (2009) Sex differences in response to citalopram: a STAR*D report. J Psychiatr Res 43(5):503–511

    PubMed  Google Scholar 

  • Zarate CA Jr, Niciu MJ (2015) Ketamine for depression: evidence, challenges and promise. World Psychiatry 14(3):348–350

    PubMed  PubMed Central  Google Scholar 

  • Zarrouf FA, Artz S, Griffith J, Sirbu C, Kommor M (2009) Testosterone and depression: systematic review and meta-analysis. J Psychiatr Pract 15:289–305

    PubMed  Google Scholar 

  • Zeidan MA, Igoe SA, Linnman C, Vitalo A, Levine JB, Klibanski A, Goldstein JM, Milad MR (2011) Estradiol modulates medial prefrontal cortex and amygdala activity during fear extinction in women and female rats. Biol Psychiatry 70(10):920–927

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zohar J, Stahl S, Moller H-J, Blier P, Kupfer D, Yamawaki S, Uchida H, Spedding M, Goodwin GM, Nutt D (2015) A review of the current nomenclature for psychotropic agents and an introduction to the neuroscience-based nomenclature. Eur Neuropsychopharmacol 25(12):2318–2325

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christina Dalla .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pavlidi, P., Kokras, N., Dalla, C. (2022). Sex Differences in Depression and Anxiety. In: Gibson, C., Galea, L.A.M. (eds) Sex Differences in Brain Function and Dysfunction. Current Topics in Behavioral Neurosciences, vol 62. Springer, Cham. https://doi.org/10.1007/7854_2022_375

Download citation

Publish with us

Policies and ethics